Huntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s disease
Year: 2017
Type: article
Study design: Observational Study
Abstract: There is widespread transcriptional dysregulation in Huntington's disease (HD) brain, but analysis is inevitably limited by advanced disease and postmortem changes. However, mutant HTT is ubiquitously expressed and acts systemically, meaning blood, which is readily available and contains cells that are dysfunctional in HD, could act as a surrogate for brain tissue. We conducted an RNA-Seq transcriptomic analysis using whole blood from two HD cohorts, and performed gene set enrichment analysis using public databases and weighted correlation network analysis modules from HD and control brain datasets. We identified dysregulated gene sets in blood that replicated in the independent cohorts, correlated with disease severity, corresponded to the most significantly dysregulated modules in the HD caudate, the most prominently affected brain region, and significantly overlapped with the transcriptional signature of HD myeloid cells. High-throughput sequencing technologies and use of gene sets likely surmounted the limitations of previously inconsistent HD blood expression studies. Our results suggest transcription is disrupted in peripheral cells in HD through mechanisms that parallel those in brain. Immune upregulation in HD overlapped with Alzheimer's disease, suggesting a common pathogenic mechanism involving macrophage phagocytosis and microglial synaptic pruning, and raises the potential for shared therapeutic approaches.
Source: Scientific Reports
DOI: 10.1038/srep44849
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
Funders: CHDI Foundation, Wellcome Trust, European Huntington's Disease Network, National Institute for Health and Care Research, Guarantors of Brain, European Commission, Rosetrees Trust, Leids Universitair Medisch Centrum, University College London Hospitals NHS Foundation Trust, Centre for Medical Systems Biology, Medical Research Council, Biotechnology and Biological Sciences Research Council
Awards: Targeting the innate immune system in Huntington's disease, G1915423305, TREAT-HD: targeting neurodegeneration in Huntington's disease, Pharmacodynamic Approaches to Demonstration of Disease-Modification in Huntington’s Disease by SEN0014196, Decoding Presymptomatic white matter changes in Huntington Disease (WIN-HD), G4825600723, Improving function in Huntington's disease through neurofeedback: using real-time fMRI to enhance cortical plasticity in early stages of the disease, Cellular pathophysiology of prion-mediated neurodegeneration - a model for understanding protein misfolding disorders, MRC Centre for Neuropsychiatric Genetics and Genomics, Integrated European –omics research project for diagnosis and therapy in rare neuromuscular and neurodegenerative diseases
OpenAlex ID: W2600619590
